These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
403 related items for PubMed ID: 32293308
1. Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis. Hansrivijit P, Cheungpasitporn W, Thongprayoon C, Ghahramani N. BMC Nephrol; 2020 Apr 15; 21(1):134. PubMed ID: 32293308 [Abstract] [Full Text] [Related]
2. Consolidation Treatment and Long-Term Prognosis of Rituximab in Minimal Change Disease and Focal Segmental Glomerular Sclerosis. Lin L, Wang W, Wu Y, Xie J, Li X, Pan X, Zhang W, Xu J, Cai Y, Ren H, Chen N. Drug Des Devel Ther; 2021 Apr 15; 15():1945-1953. PubMed ID: 34007154 [Abstract] [Full Text] [Related]
10. Idiopathic nephrotic syndrome in Syrian children: clinicopathological spectrum, treatment, and outcomes. Wannous H. Pediatr Nephrol; 2024 Aug 15; 39(8):2413-2422. PubMed ID: 38587559 [Abstract] [Full Text] [Related]
11. Efficacy of abatacept treatment for focal segmental glomerulosclerosis and minimal change disease: A systematic review of case reports, case series, and observational studies . Hansrivijit P, Puthenpura MM, Ghahramani N. Clin Nephrol; 2020 Sep 15; 94(3):117-126. PubMed ID: 32589135 [Abstract] [Full Text] [Related]
12. Efficacy and safety of rituximab in adult frequent-relapsing or steroid-dependent minimal change disease or focal segmental glomerulosclerosis: a systematic review and meta-analysis. Xue C, Yang B, Xu J, Zhou C, Zhang L, Gao X, Dai B, Yu S, Mao Z, Mei C, Xu C. Clin Kidney J; 2021 Apr 15; 14(4):1042-1054. PubMed ID: 34094516 [Abstract] [Full Text] [Related]
13. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea. Lee HY, Kim HS, Kang CM, Kim SG, Kim MJ. Clin Nephrol; 1995 Jun 15; 43(6):375-81. PubMed ID: 7554521 [Abstract] [Full Text] [Related]
14. Efficacy of low-dose rituximab in minimal change disease and prevention of relapse. Zhang J, Zhao H, Li X, Qian R, Gao P, Lu S, Ma Z. BMC Nephrol; 2023 Apr 26; 24(1):112. PubMed ID: 37101300 [Abstract] [Full Text] [Related]
15. Combined rituximab and plasmapheresis or plasma exchange for focal segmental glomerulosclerosis in adult kidney transplant recipients: a meta-analysis. Hansrivijit P, Ghahramani N. Int Urol Nephrol; 2020 Jul 26; 52(7):1377-1387. PubMed ID: 32306197 [Abstract] [Full Text] [Related]